References
- Warburg O (1956) On the origin of cancer cells. Science 123, 309-314 https://doi.org/10.1126/science.123.3191.309
- Cairns RA, Harris IS and Mak TW (2011) Regulation of cancer cell metabolism. Nat Rev Cancer 11, 85-95 https://doi.org/10.1038/nrc2981
- Wood IS and Trayhurn P (2003) Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br J Nutr 89, 3-9
- Kunkel M, Reichert TE, Benz P et al (2003) Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer 97, 1015-1024 https://doi.org/10.1002/cncr.11159
- Kang SS, Chun YK, Hur MH et al (2002) Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma. Jpn J Cancer Res 93, 1123-1128 https://doi.org/10.1111/j.1349-7006.2002.tb01214.x
- Brenton JD, Carey LA, Ahmed AA and Caldas C (2005) Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol 23, 7350-7360 https://doi.org/10.1200/JCO.2005.03.3845
- Perou CM, Sorlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406, 747-752 https://doi.org/10.1038/35021093
- Badve S, Dabbs DJ, Schnitt SJ et al (2011) Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists. Mod Pathol 24, 157-167 https://doi.org/10.1038/modpathol.2010.200
- Hussein YR, Bandyopadhyay S, Semaan A et al (2011) Glut-1 Expression Correlates with Basal-like Breast Cancer. Transl Oncol 4, 321-327 https://doi.org/10.1593/tlo.11256
- Nielsen TO, Hsu FD, Jensen K et al (2004) Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10, 5367-5374 https://doi.org/10.1158/1078-0432.CCR-04-0220
- Olayioye MA, Neve RM, Lane HA and Hynes NE (2000) The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 19, 3159-3167 https://doi.org/10.1093/emboj/19.13.3159
- Dhillon AS, Hagan S, Rath O and Kolch W (2007) MAP kinase signalling pathways in cancer. Oncogene 26, 3279-3290 https://doi.org/10.1038/sj.onc.1210421
- Lee CH, Yun HJ, Kang HS and Kim HD (1999) ERK/MAPK pathway is required for changes of cyclin D1 and B1 during phorbol 12-myristate 13-acetate-induced differentiation of K562 cells. IUBMB Life 48, 585-591 https://doi.org/10.1080/713803574
- Baldin V, Lukas J, Marcote MJ, Pagano M and Draetta G (1993) Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 7, 812-821 https://doi.org/10.1101/gad.7.5.812
- Altenberg B and Greulich KO (2004) Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics 84, 1014-1020 https://doi.org/10.1016/j.ygeno.2004.08.010
- Yang W, Zheng Y, Xia Y et al (2012) ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect. Nat Cell Biol 14, 1295-1304 https://doi.org/10.1038/ncb2629
- Shackelford DB and Shaw RJ (2009) The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer 9, 563-575 https://doi.org/10.1038/nrc2676
- Juliano RL and Haskill S (1993) Signal transduction from the extracellular matrix. J Cell Biol 120, 577-585 https://doi.org/10.1083/jcb.120.3.577
- Clark EA and Brugge JS (1995) Integrins and signal transduction pathways: the road taken. Science 268, 233-239 https://doi.org/10.1126/science.7716514
- Guan JL (1997) Role of focal adhesion kinase in integrin signaling. Int J Biochem Cell Biol 29, 1085-1096 https://doi.org/10.1016/S1357-2725(97)00051-4
- Mitra SK and Schlaepfer DD (2006) Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol 18, 516-523 https://doi.org/10.1016/j.ceb.2006.08.011
- Nagano O and Saya H (2004) Mechanism and biological significance of CD44 cleavage. Cancer Sci 95, 930-935 https://doi.org/10.1111/j.1349-7006.2004.tb03179.x
- Grover-McKay M, Walsh SA, Seftor EA, Thomas PA and Hendrix MJ (1998) Role for glucose transporter 1 protein in human breast cancer. Pathol Oncol Res 4, 115-120 https://doi.org/10.1007/BF02904704
- Schlaepfer DD, Mitra SK and Ilic D (2004) Control of motile and invasive cell phenotypes by focal adhesion kinase. Biochim Biophys Acta 1692, 77-102 https://doi.org/10.1016/j.bbamcr.2004.04.008
- Klingbeil P, Natrajan R, Everitt G et al (2010) CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplification. Breast Cancer Res Treat 120, 95-109 https://doi.org/10.1007/s10549-009-0380-7
- Xu H, Tian Y, Yuan X et al (2016) Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis. Onco Targets Ther 9, 431-444
- Jordan M and Wurm F (2004) Transfection of adherent and suspended cells by calcium phosphate. Methods 33, 136-143 https://doi.org/10.1016/j.ymeth.2003.11.011
Cited by
- YAP1-TEAD1-Glut1 axis dictates the oncogenic phenotypes of breast cancer cells by modulating glycolysis vol.95, 2017, https://doi.org/10.1016/j.biopha.2017.08.091
- Silencing of Glut1 induces chemoresistance via modulation of Akt/GSK-3β/β-catenin/survivin signaling pathway in breast cancer cells 2017, https://doi.org/10.1016/j.abb.2017.08.009
- E-cadherin expression increases cell proliferation by regulating energy metabolism through nuclear factor-κB in AGS cells vol.108, pp.9, 2017, https://doi.org/10.1111/cas.13321
- CREB1 regulates glucose transport of glioma cell line U87 by targeting GLUT1 2017, https://doi.org/10.1007/s11010-017-3080-3
- Lipocalin 2 negatively regulates cell proliferation and epithelial to mesenchymal transition through changing metabolic gene expression in colorectal cancer 2017, https://doi.org/10.1111/cas.13389
- Fibronectin expression is upregulated by PI-3K/Akt activation in tamoxifen-resistant breast cancer cells vol.50, pp.12, 2017, https://doi.org/10.5483/BMBRep.2017.50.12.096
- Renoprotective Effects of Hypoxylonol C and F Isolated from Hypoxylon truncatum against Cisplatin-Induced Cytotoxicity in LLC-PK1 Cells vol.19, pp.4, 2018, https://doi.org/10.3390/ijms19040948
- Understanding the tumour micro-environment communication network from an NOS2/COX2 perspective pp.00071188, 2019, https://doi.org/10.1111/bph.14488
- Clinicopathological and prognostic significance of GLUT1 in breast cancer vol.97, pp.48, 2018, https://doi.org/10.1097/MD.0000000000012961
- Suppressing glucose metabolism with epigallocatechin-3-gallate (EGCG) reduces breast cancer cell growth in preclinical models pp.2042-650X, 2018, https://doi.org/10.1039/C8FO01397G
- Insulin-dependent, glucose transporter 1 mediated glucose uptake and tube formation in the human placental first trimester trophoblast cells pp.1573-4919, 2018, https://doi.org/10.1007/s11010-018-3396-7
- Alpha-Mangostin Improves Insulin Secretion and Protects INS-1 Cells from Streptozotocin-Induced Damage vol.19, pp.5, 2018, https://doi.org/10.3390/ijms19051484
- TO901317 inhibits the development of Hepatocellular Carcinoma by LXRα/Glut1 decreasing the glycometabolism pp.1522-1547, 2019, https://doi.org/10.1152/ajpgi.00061.2018